Effects of Coenzyme Q10 in Early Parkinson Disease
Authors:
- Clifford W. ShultsCSClifford W. Shults
- David OakesDODavid Oakes
- Karl KieburtzKKKarl Kieburtz
- M. Flint BealMBM. Flint Beal
- Richard HaasRHRichard Haas
- Sandy PlumbSPSandy Plumb
- Jorge L. JuncosJJJorge L. Juncos
- John NuttJNJohn Nutt
- Ira ShoulsonISIra Shoulson
- Julie CarterJCJulie Carter
- Katie KompolitiKKKatie Kompoliti
- Joel S PerlmutterJPJoel S Perlmutter
Top Cited Papers
Open Access
- 1 October 2002
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 59 (10) , 1541-1550
Abstract
PARKINSON DISEASE (PD) is a degenerative neurological disorder that is characterized by resting tremor, slowness of movement, and muscular rigidity. Parkinson disease affects approximately 1% of Americans older than 65 years.1 The cardinal pathological features of PD are loss of dopaminergic neurons in the substantia nigra pars compacta and the presence of Lewy bodies in neurons in the substantia nigra and extranigral regions of the brain.2,3Keywords
This publication has 1 reference indexed in Scilit: